Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
EURETINA 2026: nAMD imaging biomarkers and real-world switch outcomes
2
EURETINA 2026: 2-year SPECTRA results and the phase 3 programme for 4D-150 gene therapy in DMO
3
EURETINA 2026: OCT biomarkers that predict, preempt and pinpoint retinal disease
4
EURETINA 2026: Gene therapy sessions to watch in Vienna
5